NEW YORK (TheStreet) -- Conatus Pharmaceuticals  (CNAT) - Get Conatus Pharmaceuticals Inc. Report soared Wednesday on high volume despite a lack of any significant news on the company.

The stock opened at $6.37, compared to its close of $6.05 on Tuesday, and then soared more than 50% to a high of $9.87 for the day. More than 6 million shares changed hands by 1:40 p.m., which easily surpassed the average volume of 352,545.

Must Read: Warren Buffett's 25 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Recommends

Image placeholder title

CNAT Price data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.